Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF FEBRUARY 04, 2012 FBO #3724
SOLICITATION NOTICE

99 -- Clinical Grade Production of Recombinant Human E-Selectin - RFQ2430914 - Statement of Work Clinical Grade Production of Recombinant Human E-Selection

Notice Date
2/2/2012
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
325412 — Pharmaceutical Preparation Manufacturing
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse, Station Support/Simplified Acquisitions, 31 Center Drive, Room 1B59, Bethesda, Maryland, 20892
 
ZIP Code
20892
 
Solicitation Number
2430914
 
Point of Contact
Susan Nsangou, Phone: 3014432104
 
E-Mail Address
nsangous@mail.nih.gov
(nsangous@mail.nih.gov)
 
Small Business Set-Aside
Total Small Business
 
Description
Statement of Work Request for Quotation 2430914 This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. This is a total small business set-aside. This solicitation number is RFQ2430914 and solicitation is issued as a request for quotation (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-55. The National Institute on Drug Abuse (NIDA) on behalf of the National Institute on Neurological Disorders and Stroke (NINDS) has a requirement for services to attain clinical grade production of recombinant human E-selectin within current good manufacturing practices (cGMP) standards in sufficient volume for use in toxicology studies and two clinical trials. See the attached Request for Quotations and the Statement of Work. Delivery is to be Bethesda, MD. Offers will also be evaluated on best value in relation to price. Quotations are to be delivered electronically to nsangous@mail.nih.gov by the due date and time. Offerors must include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications Commercial Items, with its offer. Clause at 52.212-4, Contract Terms and Condition Commercial Items, applies to this acquisition. Clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items, applies to this acquisition.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/NIDA-2/2430914/listing.html)
 
Record
SN02666420-W 20120204/120202234914-f1698531ee4103f99450e35e3b225eba (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.